Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.
‘Watchmen’ Delivers Its Best Episode Yet, Giving Us “Little Fear of Lightning”
Targeted therapy proves effective against aggressive rare blood cancer
Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.
No Comment